134 related articles for article (PubMed ID: 12549955)
1. Macular exanthema due to fumaric acid esters.
Guenther CH; Wozel G; Laske J; Aschoff R; Meurer M
Ann Pharmacother; 2003 Feb; 37(2):234-6. PubMed ID: 12549955
[TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities.
Balasubramaniam P; Stevenson O; Berth-Jones J
Br J Dermatol; 2004 Apr; 150(4):741-6. PubMed ID: 15099371
[TBL] [Abstract][Full Text] [Related]
3. Treatment of psoriasis with fumaric acid esters: results of a prospective multicentre study. German Multicentre Study.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1998 Mar; 138(3):456-60. PubMed ID: 9580799
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria with fumaric acid ester treatment for psoriasis.
Ogilvie S; Lewis Jones S; Dawe R; Foerster J
Clin Exp Dermatol; 2011 Aug; 36(6):632-4. PubMed ID: 21771009
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The Netherlands.
Balak DM; Oostveen AM; Bousema MT; Venema AW; Arnold WP; Seyger MM; Thio HB
Br J Dermatol; 2013 Jun; 168(6):1343-7. PubMed ID: 23738641
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.
Hoefnagel JJ; Thio HB; Willemze R; Bouwes Bavinck JN
Br J Dermatol; 2003 Aug; 149(2):363-9. PubMed ID: 12932244
[TBL] [Abstract][Full Text] [Related]
7. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases.
Harries MJ; Chalmers RJ; Griffiths CE
Br J Dermatol; 2005 Sep; 153(3):549-51. PubMed ID: 16120141
[TBL] [Abstract][Full Text] [Related]
8. Fumaric acid esters in necrobiosis lipoidica: results of a prospective noncontrolled study.
Kreuter A; Knierim C; Stücker M; Pawlak F; Rotterdam S; Altmeyer P; Gambichler T
Br J Dermatol; 2005 Oct; 153(4):802-7. PubMed ID: 16181464
[TBL] [Abstract][Full Text] [Related]
9. Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trial.
Balak DM; Fallah-Arani S; Venema CM; Neumann HA; Thio HB
Br J Dermatol; 2015 Mar; 172(3):754-9. PubMed ID: 25041291
[TBL] [Abstract][Full Text] [Related]
10. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test.
Padial A; Antunez C; Blanca-Lopez N; Fernandez TD; Cornejo-Garcia JA; Mayorga C; Torres MJ; Blanca M
Clin Exp Allergy; 2008 May; 38(5):822-8. PubMed ID: 18331363
[TBL] [Abstract][Full Text] [Related]
11. Fumaric acid esters in the management of psoriasis.
Balak DM
Psoriasis (Auckl); 2015; 5():9-23. PubMed ID: 29387578
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-S-transferase T1 genotyping and phenotyping in psoriasis patients receiving treatment with oral fumaric acid esters.
Gambichler T; Kreuter A; Susok L; Skrygan M; Rotterdam S; Höxtermann S; Müller M; Tigges C; Altmeyer P; Lahner N
J Eur Acad Dermatol Venereol; 2014 May; 28(5):574-80. PubMed ID: 23489263
[TBL] [Abstract][Full Text] [Related]
13. Renal dysfunction in patients taking fumaric acid esters - a retrospective cross-sectional study.
Menzies S; Ismail N; Abdalla A; Collins P; Kirby B; Holian J; Lally A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):686-691. PubMed ID: 27790753
[TBL] [Abstract][Full Text] [Related]
14. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. The German Fumaric Acid Ester Consensus Conference.
Mrowietz U; Christophers E; Altmeyer P
Br J Dermatol; 1999 Sep; 141(3):424-9. PubMed ID: 10584060
[TBL] [Abstract][Full Text] [Related]
15. Impact of fumaric acid esters on cardiovascular risk factors and depression in psoriasis: a prospective pilot study.
Schmieder A; Poppe M; Hametner C; Meyer-Schraml H; Schaarschmidt ML; Findeisen P; Benoit S; Bauer B; Schmid S; Goebeler M; Goerdt S; Ludwig-Peitsch WK
Arch Dermatol Res; 2015 Jul; 307(5):413-24. PubMed ID: 25648959
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment with fumaric acid esters in six paediatric patients with psoriasis in a psoriasis centre.
Steinz K; Gerdes S; Domm S; Mrowietz U
Dermatology; 2014; 229(3):199-204. PubMed ID: 25247273
[TBL] [Abstract][Full Text] [Related]
17. Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study.
Wain EM; Darling MI; Pleass RD; Barker JN; Smith CH
Br J Dermatol; 2010 Feb; 162(2):427-34. PubMed ID: 19519838
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of recalcitrant cutaneous sarcoidosis with fumaric acid esters.
Nowack U; Gambichler T; Hanefeld C; Kastner U; Altmeyer P
BMC Dermatol; 2002 Dec; 2():15. PubMed ID: 12498617
[TBL] [Abstract][Full Text] [Related]
19. Malignant melanoma during treatment with fumaric acid esters - coincidence or treatment-related?
Barth D; Simon JC; Wetzig T
J Dtsch Dermatol Ges; 2011 Mar; 9(3):223-5. PubMed ID: 20678147
[TBL] [Abstract][Full Text] [Related]
20. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
